KaydedilenlerDerginizi ekleyin

Dergiler / Anatolian Journal of Emergency Medicine / 2024 / Cilt: 7 Sayı: 4

Çocuk Hastalarda Sepsis Tanı ve Tedavisinde Güncel Yaklaşımlar

Current Approaches in the Diagnosis and Treatment of Sepsis in Pediatric Patients

Emel Ekşi Alp(Marmara Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı, Çocuk Acil Bilim Dalı)0000-0002-6531-6466
Dilara Türkan(Marmara Üniversitesi Tıp Fakültesi, Çocuk Sağlığı ve Hastalıkları Anabilim Dalı)0009-0004-3006-7828
Sayfa
182–189
Yayın Tarihi
2024-12-30
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Moleküler düzeydeki gelişmeler, tedavinin kişiye özel olarak uyarlanmasını sağlarken, multidisipliner yaklaşımlar klinik sonuçların iyileştirilmesine katkı sunmaktadır.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Sepsis, enfeksiyona karşı düzensiz konak yanıtıyla oluşan ve yaşamı tehdit eden organ disfonksiyonu olarak tanımlanır.
📊
Temel Bulgular & Veri:Çocuklarda sepsis, yaşa özgü farklılıklar ve komorbiditeler nedeniyle erişkinlerden farklı bir tablo çizer.
💡
Sonuç & Katkı:Moleküler düzeydeki gelişmeler, tedavinin kişiye özel olarak uyarlanmasını sağlarken, multidisipliner yaklaşımlar klinik sonuçların iyileştirilmesine katkı sunmaktadır.
🔬Tür:Literatür & Derleme Çalışması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Pediatrik sepsis · Phoenix Sepsis Skoru · acil servis

Özet

Sepsis, enfeksiyona karşı düzensiz konak yanıtıyla oluşan ve yaşamı tehdit eden organ disfonksiyonu olarak tanımlanır. Çocuklarda sepsis, yaşa özgü farklılıklar ve komorbiditeler nedeniyle erişkinlerden farklı bir tablo çizer. Bu derlemede, pediatrik sepsis tanı kriterlerindeki güncellemeler ve yönetim stratejileri ele alınmıştır. Phoenix Sepsis Skoru (PSS), pediatrik hastalarda sepsis ve septik şokun tanımlanması için geliştirilmiş yeni bir yaklaşımdır. Erken tanı, hemodinamik destek, antimikrobiyal tedavi ve bireyselleştirilmiş tedavi gibi başlıca unsurlar sepsis yönetiminde önem taşır. Moleküler düzeydeki gelişmeler, tedavinin kişiye özel olarak uyarlanmasını sağlarken, multidisipliner yaklaşımlar klinik sonuçların iyileştirilmesine katkı sunmaktadır.

Abstract

Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. In pediatric patients, sepsis manifests with distinct characteristics due to age-specific differences and comorbidities. This review examines recent updates in the pediatric sepsis diagnostic criteria and management strategies. The Phoenix Sepsis Score (PSS) represents a novel approach developed to identify sepsis and septic shock in pediatric patients. The key aspects of management encompass early diagnosis, hemodynamic support, antimicrobial therapy, and individualized treatment. Advancements at the molecular level have facilitated tailored therapies, while multidisciplinary approaches have contributed to improved clinical outcomes.

🔖

Bu Makaleye Atıf Yap

Alp, E. E., Türkan, D. (2024). Çocuk Hastalarda Sepsis Tanı ve Tedavisinde Güncel Yaklaşımlar. Anatolian Journal of Emergency Medicine, Cilt: 7 Sayı: 4, 182–189. https://doi.org/10.54996/anatolianjem.1604382

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (41)

  1. Weiss SL, Fitzgerald JC, Maffei FA, et al. Discordant identification of pediatric severe sepsis by research and clinical definitions in the SPROUT international point prevalence study. Crit Care. 2015;19(1):325. doi:10.1186/s13054-015-1055-x
  2. Schlapbach LJ, Straney L, Alexander J, et al. Mortality related to invasive infections, sepsis, and septic shock in critically ill children in Australia and New Zealand, 2002-13: a multicentre retrospective cohort study. Lancet Infect Dis. 2015;15(1):46-54. doi:10.1016/S14733099(14)71003-5
  3. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003;167(5):695-701. doi:10.1164/rccm.200207-682OC
  4. De Souza DC, Gonçalves Martin J, Soares Lanziotti V, et al. The epidemiology of sepsis in paediatric intensive care units in Brazil (the Sepsis PREvalence Assessment Database in Pediatric population, SPREAD PED): an observational study. Lancet Child Adolesc Health. 2021;5(12):873-881. doi:10.1016/S2352-4642(21)00286-8
  5. Weiss SL, Fitzgerald JC, Pappachan J, et al. Global epidemiology of pediatric severe sepsis: the sepsis prevalence, outcomes, and therapies study. Am J Respir Crit Care Med. 2015;191(10):1147-1157. doi:10.1164/rccm.201412-2323OC
  6. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*: Pediatr Crit Care Med. 2005;6(1):2-8. doi:10.1097/01.PCC.0000149131.72248.E6
  7. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference: Crit Care Med. 2003;31(4):1250-1256. doi:10.1097/01.CCM.0000050454.01978.3B
  8. Vincent JL, de Mendonça A, Cantraine F, et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Crit care Med.1998;26(11):1793-1800. doi:10.1097/00003246-199811000-00016
  9. Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi:10.1001/jama.2016.0287
  10. Matics TJ, Sanchez-Pinto LN. Adaptation and Validation of a Pediatric Sequential Organ Failure Assessment Score and Evaluation of the Sepsis-3 Definitions in Critically Ill Children. JAMA Pediatr. 2017;171(10):e172352. doi:10.1001/jamapediatrics.2017.2352
  11. Zhang X, Gui X, Yang K, Chen S, Ji Y. Prognostic performance of ageadapted SOFA and qSOFA in septic children. Crit Care Lond Engl. 2019;23(1):333. doi:10.1186/s13054-019-2609-0
  12. Balamuth F, Scott HF, Weiss SL, et al. Validation of the Pediatric Sequential Organ Failure Assessment Score and Evaluation of Third International Consensus Definitions for Sepsis and Septic Shock Definitions in the Pediatric Emergency Department. JAMA Pediatr. 2022;176(7):672-678. doi:10.1001/jamapediatrics.2022.1301
  13. Morin L, Hall M, De Souza D, et al. The Current and Future State of Pediatric Sepsis Definitions: An International Survey. Pediatrics. 2022;149(6):e2021052565. doi:10.1542/peds.2021-052565
  14. Menon K, Schlapbach LJ, Akech S, et al. Criteria for Pediatric Sepsis—A Systematic Review and Meta -Analysis by the Pediatric Sepsis Definition Taskforce*. Crit Care Med. 2022;50(1):21-36. doi:10.1097/CCM.0000000000005294
  15. Menon K, Schlapbach LJ, Akech S, et al. Pediatric Sepsis Definition—A Systematic Review Protocol by the Pediatric Sepsis Definition Taskforce. Crit Care Explor. 2020;2(6):e0123. doi:10.1097/CCE.0000000000000123
  16. Sanchez-Pinto LN, Bennett TD, DeWitt PE, et al. Development and Validation of the Phoenix Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024;331(8):675. doi:10.1001/jama.2024.0196
  17. Schlapbach LJ, Watson RS, Sorce LR, et al. International Consensus Criteria for Pediatric Sepsis and Septic Shock. JAMA. 2024;331(8):665. doi:10.1001/jama.2024.0179
  18. Starr MC, Banks R, Reeder RW, et al. Severe Acute Kidney Injury Is Associated With Increased Risk of Death and New Morbidity After Pediatric Septic Shock. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2020;21(9):e686-e695. doi:10.1097/PCC.0000000000002418
  19. Davis AL, Carcillo JA, Aneja RK, et al. American College of Critical Care Medicine Clinical Practice Parameters for Hemodynamic Support of Pediatric and Neonatal Septic Shock. Crit Care Med. 2017;45(6):1061 1093. doi:10.1097/CCM.0000000000002425
  20. Vidrine R, Atreya MR, Stalets EL. Continuum of care in pediatric sepsis: a prototypical acute care delivery model. Transl Pediatr. 2018 Oct;7(4):253-261. doi: 10.21037/tp.2018.10.01.
  21. Semler MW, Self WH, Wanderer JP, et al. Balanced Crystalloids versus Saline in Critically Ill Adults. N Engl J Med. 2018;378(9):829-839. doi:10.1056/NEJMoa1711584
  22. Hammond NE, Zampieri FG, Di Tanna GL, et al. Balanced Crystalloids versus Saline in Critically Ill Adults - A Systematic Review with MetaAnalysis. NEJM Evid. 2022;1(2):EVIDoa2100010. doi:10.1056/EVIDoa2100010
  23. Weiss SL, Balamuth F, Long E, et al. PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial. Trials. 2021;22(1):776. doi:10.1186/s13063-021-05717-4
  24. Weiss SL, Chair CV, Peters MJ, et al. Surviving Sepsis Campaign International Guidelines for the Management of Septic Shock and Sepsis-Associated Organ Dysfunction in Children. Pediatr Crit Care Med. 2020;21(2).
  25. Burgunder L, Heyrend C, Olson J, et al. Medication and Fluid Management of Pediatric Sepsis and Septic Shock. Paediatr Drugs. 2022;24(3):193-205. doi:10.1007/s40272-022-00497-z
  26. Walker SB, Conlon TW, Zhang B, et al. Clinical Signs to Categorize Shock and Target Vasoactive Medications in Warm Versus Cold Pediatric Septic Shock. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2020;21(12):1051-1058. doi:10.1097/PCC.0000000000002481
  27. Ventura AMC, Shieh HH, Bousso A, et al. Double-Blind Prospective Randomized Controlled Trial of Dopamine Versus Epinephrine as FirstLine Vasoactive Drugs in Pediatric Septic Shock. Crit Care Med. 2015;43(11):2292-2302. doi:10.1097/CCM.0000000000001260
  28. Ramaswamy KN, Singhi S, Jayashree M, Bansal A, Nallasamy K. DoubleBlind Randomized Clinical Trial Comparing Dopamine and Epinephrine in Pediatric Fluid-Refractory Hypotensive Septic Shock. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2016;17(11):e502-e512. doi:10.1097/PCC.0000000000000954
  29. Lampin ME, Rousseaux J, Botte A, Sadik A, Cremer R, Leclerc F. Noradrenaline use for septic shock in children: doses, routes of administration and complications. Acta Paediatr Oslo Nor 1992. 2012;101(9):e426-430. doi:10.1111/j.1651-2227.2012.02725.x
  30. Overgaard CB, Džavík V. Inotropes and Vasopressors: Review of Physiology and Clinical Use in Cardiovascular Disease. Circulation. 2008;118(10):1047-1056. doi:10.1161/CIRCULATIONAHA.107.728840
  31. Charbel RC, Ollier V, Julliand S, et al. Safety of early norepinephrine infusion through peripheral vascular access during transport of critically ill children. J Am Coll Emerg Physicians Open. 2021;2(2):e12395. doi:10.1002/emp2.12395
  32. Owen VS, Rosgen BK, Cherak SJ, et al. Adverse events associated with administration of vasopressor medications through a peripheral intravenous catheter: a systematic review and meta-analysis. Crit Care Lond Engl. 2021;25(1):146. doi:10.1186/s13054-021-03553-1
  33. Patregnani JT, Sochet AA, Klugman D. Short-Term Peripheral Vasoactive Infusions in Pediatrics: Where Is the Harm? Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc.2017;18(8):e378-e381. doi:10.1097/PCC.0000000000001230
  34. Strich JR, Heil EL, Masur H. Considerations for Empiric Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance. J Infect Dis. 2020;222(Suppl 2):S119-S131. doi:10.1093/infdis/jiaa221
  35. Mau LB, Bain V. Antimicrobial Therapy in Pediatric Sepsis: What Is the Best Strategy? Front Pediatr. 2022;10:830276. doi:10.3389/fped.2022.830276
  36. El-Nawawy A, Khater D, Omar H, Wali Y. Evaluation of Early Corticosteroid Therapy in Management of Pediatric Septic Shock in Pediatric Intensive Care Patients: A Randomized Clinical Study. Pediatr Infect Dis J. 2017;36(2):155-159. doi:10.1097/INF.0000000000001380
  37. Nichols B, Kubis S, Hewlett J, Yehya N, Srinivasan V. Hydrocortisone Therapy in Catecholamine-Resistant Pediatric Septic Shock: A Pragmatic Analysis of Clinician Practice and Association With Outcomes. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. 2017;18(9):e406-e414. doi:10.1097/PCC.0000000000001237
  38. Alejandria MM, Lansang MAD, Dans LF, Mantaring JB. Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock. Cochrane Database Syst Rev. 2013;2013(9):CD001090. doi:10.1002/14651858.CD001090.pub2
  39. Atreya MR, Wong HR. Precision medicine in pediatric sepsis. Curr Opin Pediatr. 2019;31(3):322-327. doi:10.1097/MOP.0000000000000753
  40. Wong HR, Caldwell JT, Cvijanovich NZ, et al. Prospective clinical testing and experimental validation of the Pediatric Sepsis Biomarker Risk Model. Sci Transl Med. 2019;11(518):eaax9000. doi:10.1126/scitranslmed.aax9000
  41. Stanski NL, Zhang B, Cvijanovich NZ, et al. Diagnostic Validation of the Updated Pediatric Sepsis BiomarkerRisk II for Acute Kidney Injury Prediction Model in Pediatric Septic Shock*. Pediatr Crit Care Med. 2024;25(11):1005-1016. doi:10.1097/PCC.0000000000003589